KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.

NCT05149326 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: KN046
DRUG: placebo

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd